Bioequivalence and Bioavailability Forum 18:59 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

IP retention EU regulatory requirements [Regulatives / Guidelines]

posted by manusyriac - India, 2018-03-08 10:20  - Posting: # 18505
Views: 505

Hi All,

I would like to seek your help in getting your thoughts on the EU regulatory requirements on the investigational medicinal product retention at sponsor manufacturing sites. Especially my focus area is the quantity of IP to be stored at manufacturing site.

Please guide me.

Regards
Manu

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,700 posts in 3,984 threads, 1,241 registered users;
online 20 (0 registered, 20 guests [including 10 identified bots]).

When puzzled, it never hurts to read the primary documents –
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed